Lv1
38 积分 2023-08-23 加入
A Multicenter, Retrospective Study Evaluating Clinical Outcomes of Ruxolitinib Therapy In Heavily Pretreated Chronic GVHD Patients With Steroid Failure
9天前
已完结
Results from oral gavage carcinogenicity studies of ruxolitinib in Tg.rasH2 mice and Sprague-Dawley (Crl:CD) rats
17天前
已完结
AZD5305 More Tolerable than Earlier PARP Agents
4个月前
已完结
ICH/FDA/EMA/WHO复方药物非临床试验指导原则比较
5个月前
已完结
Tumor suppressor functions of miRNA-375 in nasopharyngeal carcinoma through inhibition of ubiquitin-specific protease 1 expression
5个月前
已完结
Ubiquitin-specific protease 1 overexpression indicates poor prognosis and promotes proliferation, migration, and invasion of gastric cancer cells
5个月前
已完结
Mechanisms governing PARP expression, localization, and activity in cells
6个月前
已完结
Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1
6个月前
已完结
PARP Inhibitors for Breast Cancer Treatment: A Review
6个月前
已完结
皖公网安备34019202002308
